2026-04-29T12:24:05Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/133072024-11-28T15:58:14Zcom_20.500.12105_19604com_20.500.12105_2051com_20.500.12105_15322col_20.500.12105_19605col_20.500.12105_16938col_20.500.12105_16977

00925njm 22002777a 4500 dc Ponz, Ines author Nuche, Jorge author Sanchez-Sanchez, Violeta author Sanchez-Gonzalez, Javier author Blazquez-Bermejo, Zorba author Caravaca-Perez, Pedro author Garcia-Cosio-Carmena, Maria Dolores author de-Juan-Baguda, Javier S author Rodríguez-Chaverri, Adriana author Sarnago-Cebada, Fernando author Arribas-Ynsaurriaga, Fernando author Ibáñez, Borja author Delgado-Jiménez, Juan F author 2021-01 Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, for the prognostic evaluation of patients with chronic heart failure. The non-invaSive Assessment of Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess the feasibility and prognostic relevance of a non-invasive evaluation of the pulmonary artery vasculature in patients with heart failure and pulmonary hypertension. Patients will undergo a right heart catheterization, cardiac resonance imaging, and a pulmonary function test in order to identify structural and functional parameters allowing the identification of combined pre- and postcapillary pulmonary hypertension, and correlate these findings with the hemodynamic data Hearts. 2021; 2(1):5-14 10.3390/hearts2010002 2673-3846 2673-3846 Hearts http://hdl.handle.net/20.500.12105/13307 Non-Invasive Assessment of Pulmonary Vasculopathy